Search Results 641-650 of 16877 for Amphotericin B

  1. Medical Research & Education - Mayo Clinic News Network

    ... B-cell blood cancers. Susan Buckles. October 10, 2023. Preparing to biomanufacture a new CAR-T cell therapy for B-cell cancers featured. Research. Preparing ...

  2. Arthritis - Doctors and departments - Mayo Clinic

    Find a doctor whose last name begins with the letter B B · active Find a doctor whose last name begins with the letter C C · Find a doctor whose last name ...

  3. Critical Care - Doctors - Mayo Clinic

    Collura, M.D.. Pediatrician; Neonatologist. Rochester, MN. Thomas B. Comfere, M.D.. Anesthesiologist. Rochester, MN ...

  4. Medical Research & Education - Mayo Clinic News Network

    Latest stories. Mayo Clinic prepares to biomanufacture a new CAR-T cell therapy for recurring B-. Cancer.

  5. Clinical trials - Oncology (Medical)

    Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. A Study to Assess Adverse Events of ...

  6. Publications - Matthew M. Colontonio, M.D. - Mayo Clinic

    Ahmadzadeh S, Cooper HD, Asif T, Patel NR, Dorius B, Colontonio MM, Shekoohi S, Kaye AD. Efficacy of Erector Spinae Plane Block for Postoperative Pain ...

  7. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Pritt, B. Scotch, A. Rosenthal, A. Grys, TE. Kelemen, K. The brief case: the unexpected souvenir. Journal Of Clinical Microbiology. 2018 Sep; 56(9): e01387 ...

  8. Clinical trials - Oncology (Medical)

    Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. A Study of DNA/RNA Sequencing ...

  9. Drugs and Supplements that Start with C - Mayo Clinic

    Neomycin, polymyxin b, and hydrocortisone (otic route). Cassipa. Also known as. Buprenorphine/naloxone (oromucosal route, sublingual route). Cataflam. Also ...

  10. Pediatrics Clinical Trials - Medical Professionals

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...